Cardinal Health Hits $233.6 52-Week High After 5% Monthly Gain
Cardinal Health shares climbed 5% over the past month and reached a 52-week high of $233.60, marking an 11.9% gain year-to-date versus a 1.9% sector rise. The company beat consensus estimates with $2.63 EPS and 0.9% revenue upside, while trading at 22.3X forward EPS.
1. Recent Stock Performance
Shares of Cardinal Health have risen 5% in the past month to a 52-week high of $233.60, representing an 11.9% gain year-to-date compared with 1.9% growth in its medical sector and 8.6% return for the dental supplies industry.
2. Earnings Beats and Outlook
Cardinal delivered EPS of $2.63 in its February quarter, beating the consensus estimate of $2.39 and posting a 0.9% revenue surprise; fiscal 2026 earnings are projected at $10.31 per share on $259.27 billion in sales, with fiscal 2027 EPS forecast at $11.40 on $280.75 billion.
3. Valuation Profile and Rankings
The stock trades at 22.3X forward EPS and 19.7X operating cash flow versus industry averages of 18.6X and 13.4X, respectively, and carries a PEG ratio of 1.48; style scores of A for value, C for growth and D for momentum yield a combined VGM score of B and a buy rating based on rising estimates.